Xigran

drotrecogin alfa (activated) · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Xigran, covering 2007-12-07 to 2014-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Activated Protein C to Treat Acute Lung Injuries [Phase 2]